Kristensen, Frederik Pagh Bredahl
Christensen, Diana Hedevang
Mortensen, Martin Bødtker
Maeng, Michael
Kahlert, Johnny
Sørensen, Henrik Toft
Thomsen, Reimar Wernich
Article History
Received: 3 May 2023
Accepted: 13 July 2023
First Online: 26 July 2023
Declarations
:
: The study was approved by the Danish Health Data Authority and registered at Aarhus University on behalf of the Danish Data Protection Agency (No. 2016-051-000001/438/812). According to Danish legislation, ethical committee approval is not needed for register-based studies.
: Not applicable.
: M.M. is supported by a grant from the Novo Nordisk Foundation (grant number NNF22OC0074083) and has received lecture and advisory board fees from Novo Nordisk, Denmark. M.B.M has received lecture fees from Novo Nordisk, Amgen, Amarin, AstraZeneca and Sanofi. Other authors report no conflicts of interest relevant to this article. The Department of Clinical Epidemiology, Aarhus University, receives funding for other studies from companies in the form of research grants to (and administered by) Aarhus University. None of these studies have any relation to the present study.